These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29779230)

  • 1. Role of mu, but not delta or kappa, opioid receptors in context-induced reinstatement of oxycodone seeking.
    Bossert JM; Hoots JK; Fredriksson I; Adhikary S; Zhang M; Venniro M; Shaham Y
    Eur J Neurosci; 2019 Aug; 50(3):2075-2085. PubMed ID: 29779230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for kappa-, but not mu-opioid, receptor activation in acute food deprivation-induced reinstatement of heroin seeking in rats.
    Sedki F; Eigenmann K; Gelinas J; Schouela N; Courchesne S; Shalev U
    Addict Biol; 2015 May; 20(3):423-32. PubMed ID: 24725195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of mu- and delta-opioid receptors in the nucleus accumbens in cocaine-seeking behavior.
    Simmons D; Self DW
    Neuropsychopharmacology; 2009 Jul; 34(8):1946-57. PubMed ID: 19279569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of kappa opioid receptors in stress-induced reinstatement of alcohol seeking in rats.
    Funk D; Coen K; Lê AD
    Brain Behav; 2014 May; 4(3):356-67. PubMed ID: 24944865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In a Rat Model of Opioid Maintenance, the G Protein-Biased Mu Opioid Receptor Agonist TRV130 Decreases Relapse to Oxycodone Seeking and Taking and Prevents Oxycodone-Induced Brain Hypoxia.
    Bossert JM; Kiyatkin EA; Korah H; Hoots JK; Afzal A; Perekopskiy D; Thomas S; Fredriksson I; Blough BE; Negus SS; Epstein DH; Shaham Y
    Biol Psychiatry; 2020 Dec; 88(12):935-944. PubMed ID: 32305216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of opioid receptor subtypes in mediating alcohol-seeking induced by discrete cues and context.
    Marinelli PW; Funk D; Harding S; Li Z; Juzytsch W; Lê AD
    Eur J Neurosci; 2009 Aug; 30(4):671-8. PubMed ID: 19686472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats.
    Ciccocioppo R; Martin-Fardon R; Weiss F
    Neuropsychopharmacology; 2002 Sep; 27(3):391-9. PubMed ID: 12225696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.
    Largent-Milnes TM; Guo W; Wang HY; Burns LH; Vanderah TW
    J Pain; 2008 Aug; 9(8):700-13. PubMed ID: 18468954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats.
    Liu X; Palmatier MI; Caggiula AR; Sved AF; Donny EC; Gharib M; Booth S
    Psychopharmacology (Berl); 2009 Mar; 202(4):589-98. PubMed ID: 18807246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reinstatement of cocaine-seeking behavior in rats is attenuated following repeated treatment with the opioid receptor antagonist naltrexone.
    Gerrits MA; Kuzmin AV; van Ree JM
    Eur Neuropsychopharmacol; 2005 May; 15(3):297-303. PubMed ID: 15820419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats.
    Grella SL; Funk D; Coen K; Li Z; Lê AD
    Behav Brain Res; 2014 May; 265():188-97. PubMed ID: 24583188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-low-dose naltrexone reduces the rewarding potency of oxycodone and relapse vulnerability in rats.
    Leri F; Burns LH
    Pharmacol Biochem Behav; 2005 Oct; 82(2):252-62. PubMed ID: 16182352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Chronic Naltrexone on Reinstatement of Opioid-Induced Drug-Seeking Behavior and Antinociception.
    Withey SL; Bergman J; Paronis CA
    J Pharmacol Exp Ther; 2024 Mar; 389(1):5-14. PubMed ID: 37699710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mercaptoacetate induces feeding through central opioid-mediated mechanisms in rats.
    Stein JA; Znamensky V; Baumer F; Rossi GC; Pasternak GW; Bodnar RJ
    Brain Res; 2000 May; 864(2):240-51. PubMed ID: 10802031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys.
    Zamarripa CA; Naylor JE; Huskinson SL; Townsend EA; Prisinzano TE; Freeman KB
    Psychopharmacology (Berl); 2020 May; 237(5):1471-1480. PubMed ID: 32006048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat.
    Häggkvist J; Lindholm S; Franck J
    Behav Brain Res; 2009 Jan; 197(1):219-24. PubMed ID: 18793682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the opioid μ1, but not δ or κ, receptors is required for nicotine reinforcement in a rat model of drug self-administration.
    Liu X; Jernigan C
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):146-53. PubMed ID: 20965223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
    Walker BM; Koob GF
    Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleus accumbens dopamine and mu-opioid receptors modulate the reinstatement of food-seeking behavior by food-associated cues.
    Guy EG; Choi E; Pratt WE
    Behav Brain Res; 2011 Jun; 219(2):265-72. PubMed ID: 21262268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.